Anhui Sunhere Pharmaceutical Excipients Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Sunhere Pharmaceutical Excipients Co Ltd with three other companies in this sector in CHINA : Kunming Longjin Pharmaceutical Co Ltd (2019 sales of 275.29 million Chinese Renmimbi [US$39.34 million] of which 91% was Medicine Manufacture), Hubei Guangji Pharmaceutical Co., Ltd. (731.34 million Chinese Renmimbi [US$104.51 million] of which 76% was Raw Materials Series), and Zhejiang Shouxiangu Pharmaceutical Co Ltd (546.76 million Chinese Renmimbi [US$78.13 million] of which 98% was Manufacturing Industry).

Sales Analysis. During the year ended December of 2019, sales at Anhui Sunhere Pharmaceutical Excipients Co Ltd were 464.07 million Chinese Renmimbi (US$66.32 million). This is an increase of 8.3% versus 2018, when the company's sales were 428.56 million Chinese Renmimbi. This was the fifth consecutive year of sales increases at Anhui Sunhere Pharmaceutical Excipients Co Ltd (and since 2014, sales have increased a total of 94%). Sales of Pharmacy saw an increase of 8.3% in 2019, from 428.17 million Chinese Renmimbi to 463.82 million Chinese Renmimbi. Not all segments of Anhui Sunhere Pharmaceutical Excipients Co Ltd experienced an increase in sales in 2019: sales of Rent fell 37.9% to 242,388.57 Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).